Trade Summary

6 days ago, MAIER PAUL V, serving as Dir at Eton Pharmaceuticals, Inc. (ETON), sold 50,000 shares at $59.07 per share, for a total transaction value of $2,953,572.09. Following this transaction, MAIER PAUL V now holds 59,745 shares of ETON.

This sale represents a 45.56% decrease in MAIER PAUL V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 28, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 31, 2026 at 4:06 PM ET, 3 days after the trade was made.

Eton Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.